Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Naphthazarin Derivatives: Synthesis, Cytotoxic Mechanism and Evaluation of Antitumor Activity

  • You, Young-Jae (College of Pharmacy, Chungnam National University) ;
  • Zheng, Xiang-Guo (College of Pharmacy, Chungnam National University) ;
  • Kim, Yong (College of Pharmacy, Chungnam National University) ;
  • Ahn, Byung-Zun (College of Pharmacy, Chungnam National University)
  • Published : 1998.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

The rate of the GSH conjugate formation, the inhibition of DNA topoisomerase-I and the cytotoxic activity against L1210 cells of the naphthoquinones showed the same order; 5,8-dimethoxy-1,4-naphthoquinone (DMNQ)>6-(1-hydroxyethyl)-DMNQ>2-(1-hydroxyethyl)-DMNQ; the steric hindrance of the substituents, particularly 2-substutuent, in reacting with cellular nucleophiles must be the main cause for lowering the bioactivities. Acetylation of 2-(1-hydroxyethyl)-DMNQ producing 2-(acetyloxyethyl)-DMNQ potentiated the bioactivities; 2-(-hydroxyethyl)-DMNQ did not react with GSH and the enzyme, and showed $ED_{50}$ of 0.146 mg/ml for the cytotoxcity. Furthermore, the acetylation 2-(1-hydroxyethyl)-DMNQ(T/C, 119%) enhanced the T/C values for the mice bearing S-180 tumor {T/C of 2-(1-acetyloxyethyl)-DMNQ, 276%]. It was assumed that the difference in bioactivities ensued by acetylation was based on the mechanism of the so-called bioreductive alkylation.

Keywords

References

  1. Arch. Pham. Med. Chem. v.330 Baik;K.U.;Song;G.Y.;Kim;Y.;Sok;D.E.;Ahn;B.Z.
  2. Archs Biochem Biophys v.235 no.334 DiMonte;D.;Ross;D.;Bellomo;G.;Eklow;L.;Orrenius;S.
  3. Archs Biochem Biophys v.235 no.343 DiMonte;D.;Bellomo;G.;Thor;H.;Nicotera;P.;Orrenius;S.
  4. Yakhak Hoeji v.34 Antitumor effect acety;shikonin and some synthesized naphthazarines on L1210 and S-180 Systems Kim.H.;Ahn;B.Z.
  5. J. Med. Chem. v.18 Potential bioreductive alkylating agents. 5. Antineoplastic activity of quinoline-5;8-diones;naphthazarins;and naph Lin;A.J.;Lillis;B.J..;Sartorelli;A.C.
  6. Anticancer Drug Design v.11 Chirality of a 1;10-bisacetoxymitosene compound. Impact on reductive activation;DNA interstrand cross;linking and antitumao activity
  7. J. Org. Chem. v.31 Nuclear magnetic resonance spectra of substutued naphthoquinones. Influence of subxtituents on tautomerismlanisptropy;and stereochemistry in the naphthazarin system Moore;R.E.;Scheuer;P.J.
  8. Chem. Biol. Interactions v.80 Molecular mechanism of quinone cytotoxicit O'Brien;P.J.
  9. J. Biol. Chem. v.226 Effect of hydrexyl substituent position on1;4-naphthoquinone toxicity to rat hepatocytes Ollinger K;Brunmark;A.
  10. Biochemical Pharmacology v.35 Relationshio between inhibition of mitochondrial respiration by naphthoquinones;their antitumor activity and their redox potential Pisani;D.E.;Elliott;A.J.;Hinman;D.R.;Aaroson;L.M.;Pisani;R.S.
  11. Archives of Biochemistry and Biophysics v.248 The role of oxidative processes in the cytotoxicity of substitute 1;4-naphthoquinones in isolated hepatocytes Ross;D.;Thor;H.;Threadgill;M.D.;Sandy;M.S.;Smith;M.T.;Modeus;P
  12. Chem. Pham. Bull. v.29 Sankawa;U.;Otsuka;H.;Kataoka;Y.;Hoshi;Y.A.;Kuretani;K.Antitumor activity and their derivatives
  13. Bull. Chem. Soc. Jpn v.60 Synthesis of shikalkin and related compounds Terada;Y;Tanoue;A.Hatada;H.Sakamoto
  14. Cancer Chemother. rep. v.2 Thayer;P.S.;Himnelfarb;P;Watt;G.L.